Results for "GlycanAge Biomarker"

20 articles

Sugar Molecules Called Glycans May Reveal Your True Biological Age
Longevity & Aging

Sugar Molecules Called Glycans May Reveal Your True Biological Age

Glycans โ€” sugar molecules on proteins โ€” shift with stress, diet, and lifestyle, and may predict disease a decade before symptoms appear.

Press Release
May 6, 2026 0
Blood Sugar Molecules Called Glycans May Predict and Reverse Biological Aging
Longevity & Aging

Blood Sugar Molecules Called Glycans May Predict and Reverse Biological Aging

A 20,000-person study finds IgG glycan patterns track biological aging, predict mortality, and shift toward youth with interventions.

Press Release
May 20, 2026 0
GlycanAge Conference Aims to Bring Inflammaging Tests Into Clinical Practice
Longevity & Aging

GlycanAge Conference Aims to Bring Inflammaging Tests Into Clinical Practice

GlycanAge's Dubrovnik conference targets translating 25 years of inflammaging research into real clinical tools for doctors and patients.

Press Release
May 8, 2026 0
IgG Glycans Confirmed as Aging Biomarker With Plasma Exchange Cutting Biological Age Fastest
Longevity & Aging

IgG Glycans Confirmed as Aging Biomarker With Plasma Exchange Cutting Biological Age Fastest

A 20,000-person study validates IgG glycans as aging biomarkers, with therapeutic plasma exchange reducing glycan age by 0.4 years per month.

Press Release
May 22, 2026 0
Blood Metabolites in 800 Dogs Reveal New Aging Biomarkers Relevant to Humans
Longevity & Aging

Blood Metabolites in 800 Dogs Reveal New Aging Biomarkers Relevant to Humans

A class of modified amino acids found in dog blood may unlock new ways to measure and track biological aging across species.

Press Release
May 21, 2026 0
New NLRP3 Inhibitor Slashes Inflammation Markers by 85% in Phase 1 Trial
Longevity & Aging

New NLRP3 Inhibitor Slashes Inflammation Markers by 85% in Phase 1 Trial

BioAge's oral drug BGE-102 dramatically reduced hsCRP and IL-6 in obese participants with elevated inflammation, with a strong safety profile.

Press Release
Apr 23, 2026 0
At-Home Fingerprick Test Could Detect Alzheimer's Risk Years Before Symptoms
Longevity & Aging

At-Home Fingerprick Test Could Detect Alzheimer's Risk Years Before Symptoms

A new Nature Communications study shows self-collected fingerprick blood tests reliably flag Alzheimer's biomarkers, enabling earlier risk detection.

Press Release
May 15, 2026 0
Buck Institute Researcher Launches First Clinical Trial Targeting Glycation in Menopause
Longevity & Aging

Buck Institute Researcher Launches First Clinical Trial Targeting Glycation in Menopause

Dr. Vineeta Tanwar's GRACE study tests whether reducing glycation stress can improve health outcomes for postmenopausal women.

Press Release
Apr 6, 2026 0
New NLRP3 Inhibitor BGE-102 Slashes Inflammation Markers by 85% in Phase 1 Trial
Longevity & Aging

New NLRP3 Inhibitor BGE-102 Slashes Inflammation Markers by 85% in Phase 1 Trial

BioAge's oral drug BGE-102 cut a key cardiovascular risk biomarker by up to 86% in obese patients, rivaling higher doses at just 60mg daily.

Press Release
Apr 22, 2026 0
Sugar Disrupts Skin Cells From Within Accelerating Aging Beyond Collagen Damage
Longevity & Aging

Sugar Disrupts Skin Cells From Within Accelerating Aging Beyond Collagen Damage

New research reveals sugar pushes skin cells into senescence and slows repair, linking diet directly to accelerated skin and systemic aging.

Press Release
May 5, 2026 0
Popular Joint Supplement Glucosamine Linked to Faster Alzheimer's Progression
Longevity & Aging

Popular Joint Supplement Glucosamine Linked to Faster Alzheimer's Progression

A major UF study finds glucosamine users with mild cognitive impairment are 25% more likely to develop dementia, raising urgent questions for older adults.

Press Release
Jun 11, 2026 0
New Drug Slashes Inflammation Markers 85% in Early Trial โ€” A Statin Moment for Aging?
Longevity & Aging

New Drug Slashes Inflammation Markers 85% in Early Trial โ€” A Statin Moment for Aging?

BioAge's oral NLRP3 inhibitor BGE-102 cut hsCRP by ~85% in weeks, signaling a potential breakthrough in treating chronic inflammation at scale.

Press Release
Apr 23, 2026 0
Biotech Firms Race to Treat Aging Itself Using Living Cell Therapies
Longevity & Aging

Biotech Firms Race to Treat Aging Itself Using Living Cell Therapies

A new wave of biotechs is targeting aging as a root cause, using encapsulated cells and gene therapy to restore lost proteins and reverse decline.

Press Release
Apr 18, 2026 0
Why Biological Age Tests May Be More Marketing Than Medicine
Longevity & Aging

Why Biological Age Tests May Be More Marketing Than Medicine

Popular at-home biological age tests promise to reveal your 'true' age, but experts question their accuracy and clinical value.

Press Release
Mar 28, 2026 0
Alzheimer's Pathology Detected in Midlife Brains Decades Before Symptoms Appear
Longevity & Aging

Alzheimer's Pathology Detected in Midlife Brains Decades Before Symptoms Appear

A landmark study finds Alzheimer's biomarkers in 6% of middle-aged adults, predicting steep cognitive decline within 5 years.

Press Release
May 29, 2026 0
Routine Blood Test Flags Alzheimer's Risk Years Before Symptoms Appear
Longevity & Aging

Routine Blood Test Flags Alzheimer's Risk Years Before Symptoms Appear

A common immune marker in standard blood tests may predict dementia risk long before cognitive decline begins, a large NYU study finds.

Press Release
Apr 23, 2026 0
Natural Aging Molecule CaAKG Shows Promise for Restoring Alzheimer's Memory
Longevity & Aging

Natural Aging Molecule CaAKG Shows Promise for Restoring Alzheimer's Memory

Singapore researchers find calcium alpha-ketoglutarate repairs brain cell communication and restores early memory abilities in Alzheimer's models.

Press Release
Mar 29, 2026 1
Blood Protein NfL Predicts Cognitive Decline and Death Risk in Centenarians
Longevity & Aging

Blood Protein NfL Predicts Cognitive Decline and Death Risk in Centenarians

A Japanese study of 495 centenarians finds elevated NfL blood levels strongly linked to worse cognition and 36% higher mortality risk.

Press Release
May 8, 2026 0
Longevity Field Surges Forward With Biomarkers, Rapamycin Trials and Expert Insights
Longevity & Aging

Longevity Field Surges Forward With Biomarkers, Rapamycin Trials and Expert Insights

Lifespan.io reviews top rejuvenation research advances including voice-based aging biomarkers and a rapamycin-exercise clinical trial.

Press Release
Apr 24, 2026 0
Brain-Targeted GLP-1 Drug Could Shield Aging Minds from Alzheimer's and Parkinson's
Longevity & Aging

Brain-Targeted GLP-1 Drug Could Shield Aging Minds from Alzheimer's and Parkinson's

A new GLP-1 therapy engineered to cross the blood-brain barrier enters Phase II trials, targeting cognitive decline in Parkinson's and Alzheimer's.

Press Release
May 20, 2026 0
Page 1 of 2Next